RGNCY-0097 (M36 p32 inhibitor)

SOLD OUT!!  E-mail us at info@reagency.co if you are interested in this product.

M36 is a unique pharmacophore of C1q and LyP-1 tumor homing peptide associating with p32.  Mitochondrial protein p32 is a validated thearpaeutic target of cancer and is over-expressed in glioma.  M36 binds directly to p32 and inhibits LyP-1 association with p32 in vitro.  Furthermore, M36 effectively inhibits the growth of p32 over-expressed glioma cells and sensitises the cell to glucose depletion.  M36 is worthy of further development as a potent and highly selective brain penetrant targeting mitochondrial p32.

Systematic Name: 1,1'-(propane-1,3-diyl)bis(3-(3-(4,5-dihydro-1H-imidazol-2-yl)phenyl)urea)


Formula:  C23H28N8O2

Mol Wt:  448.53

PMID:  21885916

Tags: Small molecules, Cancer, glioma, Glioblastoma, M36, RGNCY-0097, LyP-1, SF188, U373, UW426, P-32